BioSpace News Archive

RauCon Pharma Partnering Conferences Limit Attendance For More Value

RauCon has now introduced limits to the number of participants of its euroPLX and asiaPLX Pharma Partnering Conferences in order to increase their value for the individual participant.

February 3, 2020

·

1 min read

BioCapital

Corteva Agriscience to Accelerate Ramp Up of Enlist E3™ Soybeans to U.S. and Canadian Farmers for 2021

Corteva, Inc. announced that the Company is accelerating the ramp-up of Enlist E3™ soybeans to U.S. and Canadian farmers over the next five years – reinforcing the Company’s commitment to its Enlist technology and continued focus on bringing greater choice and value to growers.

February 3, 2020

·

6 min read

Policy

MedAlliance Receives CE Mark Approval for SELUTION SLR™ Sirolimus Drug Eluting Balloon for Endovascular Applications

MedAlliance has announced the award of its first CE Mark approval: for SELUTION SLR™, a novel Sirolimus Drug Eluting Balloon, for the treatment of peripheral arterial disease.

February 3, 2020

·

2 min read

Pharm Country

Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution

Quest plans to standardize its immunoassay testing across 19 core laboratories, including a new flagship lab in Clifton, New Jersey with Atellica Solution and automation

February 3, 2020

·

4 min read

A Revolution in Laparoscopic Training: KARL STORZ and VirtaMed Leap Beyond VR Simulation

KARL STORZ, the leading endoscopy manufacturer, and VirtaMed, world leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.

February 3, 2020

·

4 min read

Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan

Teva Pharmaceutical Industries Ltd. announced positive results from two Phase 2/3 trials evaluating AJOVY® in patients in Japan. AJOVY is under development in Japan by Otsuka Pharmaceutical Co., Ltd. as part of a May 2017 exclusive license agreement for development and sales of AJOVY in Japan.

February 3, 2020

·

8 min read

Business

Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics

License agreement to utilise Affimer proteins in next generation cell and gene therapies

February 3, 2020

·

3 min read

Policy

Mesoblast Submits Completed Biologics License Application for Ryoncil™ to US FDA

Mesoblast Limited announced that it has submitted its completed Biologics License Application to the United States Food and Drug Administration for Ryoncil™, its lead allogeneic cell therapy for the treatment of children with steroid-refractory acute graft versus host disease.

February 3, 2020

·

5 min read

Policy

United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint

United Therapeutics Corporation announced topline results from the phase 2/3 DISTINCT clinical study evaluating Unituxin® Injection added to irinotecan compared to irinotecan or topotecan alone in patients with relapsed or refractory small cell lung cancer.

February 3, 2020

·

14 min read

Business

Amir Shojaei, PharmD, PhD, to Join iVeena Board of Directors

iVeena Delivery Systems, Inc., a clinical stage biopharmaceutical company with developmental products in cornea and cataract, announces the appointment of Dr. Amir Shojaei to the iVeena Board of Directors.

February 3, 2020

·

2 min read